Discover comprehensive insights into the global biochip market, providing revenue analysis, trends, and forecasts to 2029. Examine segmented data by ...

Real change takes a long time, and when it happens, it must be recognized. The FDA and the NIH have announced their move away ...

The latest inspection comes 2 1/2 years after the agency allowed Sun Pharma to keep shipping some drugs to Americans even ...

Agreement with global pharmaceutical solutions provider enhances commercial infrastructure and reinforces launch readiness ...

Liminatus merged with blank check company Iris Acquisition Corp. in April to create a newly combined company called Liminatus Pharma Inc.